Skip to main content
. 2025 Jul;64(4):733–743. doi: 10.30802/AALAS-JAALAS-25-042

Table 3.

Differing minimum inhibitory concentration antimicrobial susceptibilities for S. aureus

Study ID PEN OX/ME CEFO CIP ENO MBO CLN DX FLOR
A1 0.12 0.5 2 R >4 >4 0.25 R 8
A2 0.06 <0.25 1 R >4 >4 0.25 <0.12 <4
B1 0.12 <0.25 2 S <0.5 <0.5 0.25 <0.12 8
B2 0.06 <0.25 2 S <0.5 <0.5 0.25 <0.12 <4
D1 0.12 <0.25 1 R >4 >4 0.25 0.25 <4
D2 0.06 <0.25 1 R >4 >4 0.25 <0.12 <4
G1 0.12 <0.25 2 S <0.5 <0.5 0.25 <0.12 <4
G2 0.12 0.5 2 S <0.5 <0.5 0.25 <0.12 <4
L1 <0.03 <0.25 1 S <0.5 <0.5 <0.12 <0.12 <4
L2 0.12 0.5 2 S <0.5 <0.5 0.25 <0.12 8
P1 0.12 0.5 2 S <0.5 <0.5 0.25 0.25 <4
P2 0.12 0.5 2 S <0.5 <0.5 0.25 <0.12 <4
S1 0.12 <0.25 2 S <0.5 <0.5 0.25 <0.12 <4
S2 0.12 0.5 2 S <0.5 <0.5 <0.12 <0.12 <4
T1 0.12 <0.25 2 S <0.5 <0.5 0.25 <0.12 <4
T2 0.12 0.5 2 S <0.5 <0.5 0.25 <0.12 <4

Prestudy isolates are designated with the number 1 following the animal ID and poststudy isolates are designated with the number 2 following the animal ID. Unshaded MICs indicate susceptibility, yellow-shaded MICs indicate intermediate susceptibility, and red-shaded MICs indicate resistant susceptibilities. When numeric MICs were not provided, S and R are used to designate susceptible and resistant results, respectively. Key: PEN, penicillin; OX/ME, oxacillin/methicillin; CEFO, cefovecin; CIP, ciprofloxacin; ENO, enrofloxacin; MBO, marbofloxacin; CLN, clindamycin; DX, doxycycline; FLOR, florfenicol. In addition, all isolates were susceptible to amoxicillin (>0.25), amoxicillin-clavulanic acid (>0.25), imipenem (S), cephalexin (>2), cefpodoxime (>2), amikacin (>2), gentamicin (>0.5), azithromycin (S), erythromycin (>0.25), mupirocin (>1), chloramphenicol (>4), TMS (>10), minocycline (>0.5), and rifampin (>0.03).